9-136365192-C-T

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_052813.5(CARD9):​c.1383G>A​(p.Pro461Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00514 in 1,610,312 control chromosomes in the GnomAD database, including 64 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0059 ( 10 hom., cov: 33)
Exomes 𝑓: 0.0051 ( 54 hom. )

Consequence

CARD9
NM_052813.5 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -4.73
Variant links:
Genes affected
CARD9 (HGNC:16391): (caspase recruitment domain family member 9) The protein encoded by this gene is a member of the CARD protein family, which is defined by the presence of a characteristic caspase-associated recruitment domain (CARD). CARD is a protein interaction domain known to participate in activation or suppression of CARD containing members of the caspase family, and thus plays an important regulatory role in cell apoptosis. This protein was identified by its selective association with the CARD domain of BCL10, a postive regulator of apoptosis and NF-kappaB activation, and is thought to function as a molecular scaffold for the assembly of a BCL10 signaling complex that activates NF-kappaB. Several alternatively spliced transcript variants have been observed, but their full-length nature is not clearly defined. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 9-136365192-C-T is Benign according to our data. Variant chr9-136365192-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 365833.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-4.73 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00589 (897/152176) while in subpopulation NFE AF= 0.00612 (416/67984). AF 95% confidence interval is 0.00563. There are 10 homozygotes in gnomad4. There are 533 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 10 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CARD9NM_052813.5 linkc.1383G>A p.Pro461Pro synonymous_variant Exon 11 of 13 ENST00000371732.10 NP_434700.2 Q9H257-1A0A024R8F1
CARD9NM_052814.4 linkc.1383G>A p.Pro461Pro synonymous_variant Exon 11 of 13 NP_434701.1 Q9H257-2
LOC124902309XR_007061863.1 linkn.84+1740C>T intron_variant Intron 1 of 1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CARD9ENST00000371732.10 linkc.1383G>A p.Pro461Pro synonymous_variant Exon 11 of 13 1 NM_052813.5 ENSP00000360797.5 Q9H257-1
ENSG00000289701ENST00000696169.1 linkn.*430G>A non_coding_transcript_exon_variant Exon 11 of 13 ENSP00000512460.1
ENSG00000289701ENST00000696169.1 linkn.*430G>A 3_prime_UTR_variant Exon 11 of 13 ENSP00000512460.1

Frequencies

GnomAD3 genomes
AF:
0.00590
AC:
897
AN:
152058
Hom.:
10
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000821
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000851
Gnomad ASJ
AF:
0.000288
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.0402
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00612
Gnomad OTH
AF:
0.00287
GnomAD3 exomes
AF:
0.00593
AC:
1455
AN:
245460
Hom.:
15
AF XY:
0.00610
AC XY:
815
AN XY:
133590
show subpopulations
Gnomad AFR exome
AF:
0.000752
Gnomad AMR exome
AF:
0.000755
Gnomad ASJ exome
AF:
0.000201
Gnomad EAS exome
AF:
0.000328
Gnomad SAS exome
AF:
0.000196
Gnomad FIN exome
AF:
0.0401
Gnomad NFE exome
AF:
0.00566
Gnomad OTH exome
AF:
0.00546
GnomAD4 exome
AF:
0.00507
AC:
7387
AN:
1458136
Hom.:
54
Cov.:
31
AF XY:
0.00497
AC XY:
3609
AN XY:
725570
show subpopulations
Gnomad4 AFR exome
AF:
0.000508
Gnomad4 AMR exome
AF:
0.000626
Gnomad4 ASJ exome
AF:
0.000230
Gnomad4 EAS exome
AF:
0.000327
Gnomad4 SAS exome
AF:
0.000197
Gnomad4 FIN exome
AF:
0.0353
Gnomad4 NFE exome
AF:
0.00480
Gnomad4 OTH exome
AF:
0.00343
GnomAD4 genome
AF:
0.00589
AC:
897
AN:
152176
Hom.:
10
Cov.:
33
AF XY:
0.00716
AC XY:
533
AN XY:
74404
show subpopulations
Gnomad4 AFR
AF:
0.000819
Gnomad4 AMR
AF:
0.000850
Gnomad4 ASJ
AF:
0.000288
Gnomad4 EAS
AF:
0.000193
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.0402
Gnomad4 NFE
AF:
0.00612
Gnomad4 OTH
AF:
0.00284
Alfa
AF:
0.00517
Hom.:
2
Bravo
AF:
0.00244
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.00360
EpiControl
AF:
0.00374

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Aug 01, 2023
CeGaT Center for Human Genetics Tuebingen
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

CARD9: BP4, BP7 -

-
Breakthrough Genomics, Breakthrough Genomics
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Predisposition to invasive fungal disease due to CARD9 deficiency Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
1.5
DANN
Benign
0.65
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.3

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.11
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs138344913; hg19: chr9-139259644; API